US FDA expands approval for J&J's drug for rare blood disorder

The US Food and Drug Administration (FDA) has approved an expanded use of Johnson & Johnson's drug to treat a rare blood disorder, broadening the treatment options available for affected patients.

This Wire brief sits within Fusion42's coverage of Biotech.